Urologic Imaging

Which Imaging Study Best Evaluates Complicated Recurrent UTIs in Females?

·
Which Imaging Study Best Evaluates Complicated Recurrent UTIs in Females?

A 45-year-old female with type 2 diabetes presents with her fourth urinary tract infection (UTI) this year. Despite appropriate antibiotic courses based on culture sensitivities, she relapsed within two weeks of finishing her most recent treatment. You suspect an underlying anatomic or functional cause is driving these frequent, refractory infections. The clinical question is no longer if she has a UTI, but why she keeps getting them. This article details the evidence-based imaging workflow for this exact scenario of complicated or refractory recurrent UTIs. For this presentation, the American College of Radiology (ACR) finds Magnetic Resonance Urography (MRU) without and with IV contrast to be Usually appropriate.

Who Fits This Clinical Scenario?

This guidance applies specifically to female patients with recurrent lower urinary tract infections (UTIs) who fall into a “complicated” category. This includes patients who fail to respond to conventional antibiotic therapy, experience frequent reinfections (defined as two or more in six months, or three or more in a year), or have known underlying risk factors that predispose them to infection.

Key inclusion criteria for this imaging workup are:

  • Frequent Relapses or Reinfections: A pattern of recurring infections despite adequate treatment.
  • Known Risk Factors: Conditions such as diabetes mellitus, immunosuppression, neurogenic bladder, known urinary tract stones, or a history of urologic surgery.
  • Nonresponse to Therapy: Persistence of symptoms or positive cultures after a standard course of antibiotics.
  • Suspicion of Anatomic Abnormality: Clinical findings like hematuria, pneumaturia, or a palpable mass that suggest a structural cause.

This workflow is distinct from the management of a female patient with uncomplicated recurrent UTIs. In a younger, healthy patient with no underlying risk factors or signs of complicated infection, imaging is often not indicated as a first step. This guidance is for the next level of investigation, when the clinical picture suggests a hidden driver of infection.

What Diagnoses Are You Working Up in This Scenario?

When ordering imaging for complicated recurrent UTIs, the goal is to identify an underlying structural or functional abnormality that is creating a nidus for infection. The differential diagnosis is broad, spanning congenital anomalies, acquired conditions, and neoplastic processes.

A primary consideration is an anatomic abnormality of the urinary tract. This includes conditions like a duplex collecting system, ureterocele, ectopic ureter, or significant pelvic organ prolapse that leads to incomplete bladder emptying and urine stasis. These variants can disrupt normal urine flow, creating an environment where bacteria can thrive.

Urolithiasis or nephrolithiasis is another key diagnostic target. Urinary stones, even small ones, can harbor bacteria and act as a persistent source for recurrent infections. They may be asymptomatic aside from the UTIs they precipitate.

Less common but critical possibilities include fistulas and diverticula. An enterovesical fistula (a connection between the bowel and bladder) or a vesicovaginal fistula can continuously seed the urinary tract with bacteria. Similarly, a urethral diverticulum—an outpouching from the urethra—can trap urine and become a focus of chronic infection.

Finally, while less common, an underlying urothelial neoplasm of the bladder, ureter, or renal pelvis must be excluded. Tumors can cause obstruction, ulcerate, and become secondarily infected, presenting with symptoms that mimic a simple UTI.

Why Is MRU without and with IV contrast the Recommended Study for This Presentation?

For a comprehensive evaluation of complicated recurrent UTIs, Magnetic Resonance Urography (MRU) without and with IV contrast is rated Usually appropriate by the ACR. This recommendation is based on its superior soft-tissue contrast and ability to provide both anatomic and functional information without the use of ionizing radiation.

MRU excels at delineating the renal parenchyma, collecting systems, ureters, and bladder wall. The multiphasic approach, including non-contrast sequences and post-contrast nephrographic and excretory phases, allows for detailed assessment. It is highly sensitive for detecting inflammation, abscess formation, complex cysts, and potential neoplasms—diagnoses that may be subtle or missed on other modalities. The lack of ionizing radiation (0 mSv) is a significant advantage, particularly in younger patients or those who may require future imaging.

Two key alternatives have limitations in this specific context:

  • CT Urography (CTU) without and with IV contrast: While also rated Usually appropriate, CTU delivers a substantial radiation dose (☢☢☢☢ 10-30 mSv). Although it is excellent for detecting stones and providing anatomic detail, MRU’s superior soft-tissue resolution often makes it the preferred initial study when the differential includes inflammation, fistulas, or soft-tissue masses.
  • Ultrasound (US) of the kidneys and bladder: Rated as May be appropriate, ultrasound is a valuable initial tool for assessing for hydronephrosis or large, simple stones. However, it is operator-dependent and has limited sensitivity for detecting small stones, subtle urothelial thickening, ureteral abnormalities, or fistulas. It often serves as a screening tool but lacks the comprehensive detail needed for this complex clinical question.

When ordering MRU, specifying the clinical indication of recurrent complicated UTIs is crucial for the radiology team to tailor the protocol for optimal visualization of the entire urinary tract, including delayed excretory phase imaging.

What’s Next After MRU without and with IV contrast? Downstream Workflow

The results of the MRU will guide the subsequent clinical pathway, which typically involves urologic consultation for definitive management. The downstream workflow depends on whether the findings are positive, negative, or indeterminate.

If the MRU is positive for a specific abnormality:

  • Anatomic Variant (e.g., ureterocele, obstruction): The next step is referral to urology for potential surgical correction or endoscopic management.
  • Urolithiasis: Depending on stone size, location, and composition, management may range from medical expulsive therapy to procedures like ureteroscopy or lithotripsy.
  • Suspicious Mass or Stricture: This finding requires urgent urologic evaluation, which will likely include cystoscopy and/or ureteroscopy with biopsy to rule out malignancy.
  • Fistula or Diverticulum: These findings typically necessitate surgical repair. Further characterization with a study like a voiding cystourethrography (May be appropriate) may be considered for functional assessment before surgery.

If the MRU is negative: A negative, high-quality MRU provides strong evidence against a significant anatomic cause for the recurrent UTIs. The focus then shifts back to functional or medical causes. This may involve urodynamic testing to assess for voiding dysfunction, a review of antimicrobial prophylaxis strategies, or evaluation for non-structural causes like atrophic vaginitis in postmenopausal women.

If the MRU is indeterminate: In rare cases, a finding may be unclear. For example, mild urothelial thickening could represent inflammation or an early neoplasm. In this situation, the next step is often direct visualization via cystoscopy to resolve the diagnostic uncertainty.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup for complicated recurrent UTIs requires careful consideration to avoid common diagnostic errors.

  • Inadequate Clinical History: Failing to provide the radiologist with the specific context of “complicated recurrent UTIs” may result in a generic MRI protocol that omits crucial excretory phase imaging.
  • Ignoring Post-Void Residuals: Whether assessing via ultrasound or bladder scanner, overlooking a high post-void residual volume can mean missing a functional cause of stasis, like neurogenic bladder or obstruction.
  • Over-reliance on Ultrasound: While a good screening tool, a negative renal and bladder ultrasound does not sufficiently rule out the complex pathologies (e.g., small stones, fistulas, diverticula) being investigated in this scenario.
  • Forgetting Gadolinium Contraindications: Before ordering a contrast-enhanced MRU, always screen for severe renal insufficiency (low eGFR) or a history of allergic reaction to gadolinium-based contrast agents.

If a patient presents with systemic signs of infection, such as fever, flank pain, and leukocytosis, this suggests pyelonephritis or urosepsis. This is a more urgent situation requiring immediate treatment and often inpatient evaluation, which may alter the initial imaging choice toward a faster study like CT.

Related ACR Topics and Tools

For a comprehensive understanding of imaging for recurrent UTIs and related clinical scenarios, the following resources are valuable.

Frequently Asked Questions

Why is MR Urography preferred over CT Urography if both are ‘Usually Appropriate’?

MR Urography (MRU) is often preferred because it provides excellent soft-tissue detail comparable to CT Urography (CTU) without using any ionizing radiation. This is a significant advantage, especially in younger patients or those who might need multiple scans over time. While CTU is faster and better for detecting calcified stones, MRU’s superior ability to characterize inflammation, soft-tissue masses, and fistulas makes it the top choice for the broad differential in complicated UTIs.

What if my patient has a contraindication to MRI, like a non-compatible pacemaker?

If a patient cannot undergo an MRI, CT Urography (CTU) without and with IV contrast is an excellent alternative and is also rated ‘Usually appropriate’ by the ACR. It provides comprehensive anatomic detail of the urinary tract. You must weigh the diagnostic need against the radiation exposure (10-30 mSv) and ensure the patient has adequate renal function for iodinated contrast.

Is a voiding cystourethrogram (VCUG) necessary in this workup?

A VCUG is rated ‘May be appropriate’ and is not typically a first-line study for this scenario in adults. Its primary role is to evaluate for vesicoureteral reflux (VUR) and urethral abnormalities like diverticula. It may be considered as a downstream test if an MRU is negative but there remains a high clinical suspicion for VUR or a urethral diverticulum, or to further characterize a finding seen on the initial MRU.

Should I order imaging after the first or second UTI?

Imaging is generally not recommended after a first or second uncomplicated UTI. This advanced imaging workflow is reserved for patients with a pattern of recurrent infections (e.g., 3+ in a year) or those with complicating factors like diabetes, immunosuppression, known anatomic abnormalities, or failure to respond to standard antibiotic therapy.

Does the MRU need to be done with and without IV contrast?

Yes, for this indication, both non-contrast and post-contrast sequences are essential. Non-contrast images are excellent for detecting hemorrhage and certain types of stones. The post-contrast images, including the delayed excretory phase, are critical for evaluating renal function, identifying areas of inflammation or abscess (which will enhance), characterizing masses, and delineating the anatomy of the ureters and collecting system.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 26, 2026